Want to join the conversation?
$BAX expects 2016 sales growth of 2-3% excluding impact of FX, and after adjusting for impact of both FX and increased U.S. competition for cyclophosphamide, $BAX sees full-year sales growth of 3-4%. On reported basis, including FX impact, $BAX sees sales to decline about 1% and EPS from continuing operations, before special items, of $1.46-1.54.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!
$SGY is expected to achieve $6.17 price target in next year, with a minimum target of $3.00, due to the price increase of 27.85% to $6.29 during the last trading session.